Please try another search
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Name | Age | Since | Title |
---|---|---|---|
Dawn Coverley | 58 | 2005 | Founder, Chief Scientific Officer & Non-Executive Director |
Nigel R. Lee | 62 | 2021 | Finance Director & Executive Director |
Morgan Williams | - | 2005 | Head of Commercialisation for Yorkshire Cancer Research and Board Observer |
John Michael Treacy | 43 | 2021 | Non-Executive Director |
Allan John Syms | 67 | 2019 | Executive Chairman |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review